136 related articles for article (PubMed ID: 8236362)
1. Generation of pharmacokinetic data during routine therapeutic drug monitoring: Bayesian approach vs. pharmacokinetic studies.
el Desoky E; Meinshausen J; Bühl K; Engel G; Harings-Kaim A; Drewelow B; Klotz U
Ther Drug Monit; 1993 Aug; 15(4):281-8. PubMed ID: 8236362
[TBL] [Abstract][Full Text] [Related]
2. Disposition of intravenous theophylline in asthmatic children: Bayesian approach vs direct pharmacokinetic calculations.
el Desoky E; Ghazal MH; Mohamed MA; Klotz U
Jpn J Pharmacol; 1997 Sep; 75(1):13-20. PubMed ID: 9334881
[TBL] [Abstract][Full Text] [Related]
3. Bayesian pharmacokinetics of gentamicin in a haemodialysis population.
Vercaigne LM; Ariano RE; Zacharias JM
Clin Pharmacokinet; 2004; 43(3):205-10. PubMed ID: 14871157
[TBL] [Abstract][Full Text] [Related]
4. A Population Pharmacokinetic Model of Gentamicin in Pediatric Oncology Patients To Facilitate Personalized Dosing.
Llanos-Paez CC; Staatz CE; Lawson R; Hennig S
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533244
[TBL] [Abstract][Full Text] [Related]
5. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
Carlsson KC; Hoem NO; Glauser T; Vinks AA
Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of digoxin in pediatric patients.
Martín-Suárez A; Falcao AC; Outeda M; Hernández FJ; González MC; Quero M; Arranz I; Lanao JM
Ther Drug Monit; 2002 Dec; 24(6):742-5. PubMed ID: 12451291
[TBL] [Abstract][Full Text] [Related]
7. Prediction of gentamicin concentrations in neonates and infants using a Bayesian pharmacokinetic model.
Rodvold KA; Gentry CA; Plank GS; Kraus DM; Nickel E; Gross JR
Dev Pharmacol Ther; 1993; 20(3-4):211-9. PubMed ID: 7828456
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a novel Bayesian method for individualizing theophylline dosage.
Stein U; Oellerich M; Sybrecht GW; Schneider B
J Clin Chem Clin Biochem; 1988 Jun; 26(6):405-14. PubMed ID: 3411295
[TBL] [Abstract][Full Text] [Related]
9. [Individualized monitoring of the therapy with gentamycin using pharmacokinetic methods. Which method to choose?].
Carvalho A; Fonseca C; Falcão F; Pereira TA; Freitas O; Parrinha A; Costa M; Rodrigues MJ; Ceia F; Luís AS
Acta Med Port; 1996; 9(7-9):187-95. PubMed ID: 9005695
[TBL] [Abstract][Full Text] [Related]
10. Development and Evaluation of a Gentamicin Pharmacokinetic Model That Facilitates Opportunistic Gentamicin Therapeutic Drug Monitoring in Neonates and Infants.
Germovsek E; Kent A; Metsvaht T; Lutsar I; Klein N; Turner MA; Sharland M; Nielsen EI; Heath PT; Standing JF
Antimicrob Agents Chemother; 2016 Aug; 60(8):4869-77. PubMed ID: 27270281
[TBL] [Abstract][Full Text] [Related]
11. A population pharmacokinetic analysis of the influence of nutritional status of digoxin in hospitalized Korean patients.
Choi SA; Yun HY; Lee ES; Shin WG
Clin Ther; 2014 Mar; 36(3):389-400. PubMed ID: 24612944
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of gentamicin. Use of the nonparametric expectation maximisation (NPEM) algorithm.
Kisor DF; Watling SM; Zarowitz BJ; Jelliffe RW
Clin Pharmacokinet; 1992 Jul; 23(1):62-8. PubMed ID: 1617859
[TBL] [Abstract][Full Text] [Related]
13. Individualising aminoglycoside dosage regimens after therapeutic drug monitoring: simple or complex pharmacokinetic methods?
Tod MM; Padoin C; Petitjean O
Clin Pharmacokinet; 2001; 40(11):803-14. PubMed ID: 11735603
[TBL] [Abstract][Full Text] [Related]
14. Abbott PKS system: a new version for applied pharmacokinetics including Bayesian estimation.
Lacarelle B; Pisano P; Gauthier T; Villard PH; Guder F; Catalin J; Durand A
Int J Biomed Comput; 1994 Jun; 36(1-2):127-30. PubMed ID: 7927851
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of theophylline. II: Intravenous infusion to patients with stable chronic airway obstruction.
Yano I; Tanigawara Y; Yasuhara M; Okumura K; Kawakatsu K; Nishimura K; Hori R
Biol Pharm Bull; 1993 May; 16(5):501-5. PubMed ID: 8364499
[TBL] [Abstract][Full Text] [Related]
16. Bayesian forecasting of serum gentamicin concentrations in intensive care patients.
Rodvold KA; Pryka RD; Kuehl PG; Blum RA; Donahue P
Clin Pharmacokinet; 1990 May; 18(5):409-18. PubMed ID: 2335046
[TBL] [Abstract][Full Text] [Related]
17. Determination of digoxin clearance in Japanese elderly patients for optimization of drug therapy: a population pharmacokinetics analysis using nonlinear mixed-effects modelling.
Yukawa M; Yukawa E; Suematsu F; Takiguchi T; Ikeda H; Aki H; Mimemoto M
Drugs Aging; 2011 Oct; 28(10):831-41. PubMed ID: 21970310
[TBL] [Abstract][Full Text] [Related]
18. Benchmarking therapeutic drug monitoring software: a review of available computer tools.
Fuchs A; Csajka C; Thoma Y; Buclin T; Widmer N
Clin Pharmacokinet; 2013 Jan; 52(1):9-22. PubMed ID: 23196713
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetic investigation of digoxin in Japanese neonates.
Yukawa E; Akiyama K; Suematsu F; Yukawa M; Minemoto M
J Clin Pharm Ther; 2007 Aug; 32(4):381-6. PubMed ID: 17635340
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of therapeutic drug monitoring of digoxin and gentamicin in the saliva of children.
Berkovitch M; Bistritzer T; Aladjem M; Burtin P; Dagan T; Chen-Levi Z; Freedom R; Koren G
Ther Drug Monit; 1998 Jun; 20(3):253-6. PubMed ID: 9631920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
